International Stem Cell Corporation
ISCO
$0.11
-$0.001-0.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 108.80% | -205.04% | 155.61% | 53.28% | -249.62% |
| Total Depreciation and Amortization | 1.89% | 6.00% | 2.04% | 2.08% | 2.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.83% | -36.88% | 21.20% | -20.22% | 32.68% |
| Change in Net Operating Assets | -295.09% | 139.85% | -66.94% | -181.94% | 606.78% |
| Cash from Operations | -128.79% | 1,017.39% | 111.92% | -219.88% | 159.68% |
| Capital Expenditure | 97.30% | 69.17% | -1,400.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.33% | -400.00% | 200.00% | 66.67% | -- |
| Cash from Investing | 92.50% | 66.39% | -1,222.22% | -200.00% | 78.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -552.94% | 117.71% | 52.48% | -227.85% | 229.17% |